Italia markets open in 46 minutes

Danaher Corporation (0R2B.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
264,01+15,05 (+6,05%)
Alla chiusura: 06:13AM BST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850

Impiegati a tempo pieno61.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Steven M. RalesCo-Founder & ChairmanN/DN/D1951
Mr. Rainer M. BlairPresident, CEO & Director5,33MN/D1964
Mr. Mitchell P. RalesCo-Founder & DirectorN/DN/D1957
Mr. Matthew R. McGrewCFO & Executive VP2,56MN/D1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2,09MN/D1962
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources1,66MN/D1977
Mr. Joakim WeidemanisExecutive Officer2,76M6,5M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerN/DN/DN/D
Mr. John BedfordVice President of Investor RelationsN/DN/DN/D
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1,93MN/D1967
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Governance aziendale

L'ISS Governance QualityScore di Danaher Corporation al 1 luglio 2024 è 8. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 10; diritti degli azionisti: 2; retribuzione: 1.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.